Roflumilast

National NHS prescribing (Prescription Cost Analysis) · Cromoglycate, leukotriene and phosphodesterase type-4 inhib

Data updated March 2026

Roflumilast was ranked 895th of 1,794 medicines by items in March 2026, with 995 items, up 14.1% on a year earlier.

995items

Dispensed in March 2026

NHSBSA Prescription Cost Analysis

£31,065

Net ingredient cost · March 2026

NHSBSA PCA

11,173items

Dispensed in the last 12 months

NHSBSA PCA

Figure 1. Roflumilast: national items dispensed by month

Source: NHSBSA Prescription Cost Analysis, to March 2026

Download CSV

Embed this chart

<iframe src="https://pharmainsight.co.uk/embed/medicines/roflumilast-0303030b0" width="100%" height="280" style="border:0" loading="lazy" title="Roflumilast: NHS prescribing in England — PharmaInsight"></iframe>

Top presentations, March 2026

The individual products dispensed under Roflumilast, by items this month.

Presentations of Roflumilast, March 2026
Presentation	Items	Net ingredient cost
Roflumilast 500microgram tablets	865	£25,822
Roflumilast 250microgram tablets	119	£4,831
Daxas 500microgram tablets	10	£377
Daxas 250microgram tablets	1	£35

Compare Roflumilast with

Other medicines in the same BNF section, by prescribing volume.